All News

The Food and Drug Administration proposed new rules that will provide pharmaceutical companies more latitude in promoting off-label uses of medicines, biologics and medical devices.

American Home Products, the Madison, NJ-based parent company of Wyeth-Ayerst, and Monsanto Company, the St. Louis-based parent company of Searle, announced June 1 that they will merge.

Bayer AG, Wuppertal, Germany, indicated that it may be considering a merger with another major pharmaceutical company.

Learn to make decisions and before you are forced to.

Empower yourself! Develop leadership and accountability.

The tobacco industry settled one of several lawsuits that have been brought against it by various state governments and health plans.

Stress-related "burnout" can be a major problem in fast-paced professions.

Americans are engaged in a massive movement toward healthier living, which includes disease prevention and maintenance of healthy lifestyle habits.

A majority of American patients are pleased with their physicians, according to a new survey released by the Pfizer Medical Humanities Initiative.

Face to face with the realities of a physician's day.

The launch of Viagra, Pfizer's new oral medication for erectile dysfunction, invigorated an otherwise sleepy sexual dysfunction market, sparked debate among health plan insurers and established itself as the most successful launch ever.

The majority of Americans want to hold their managed care health plans legally accountable, according to the results of a recent public opinion poll released by the American Psycho-logical Association, Washington.

If it seems like there are more pharmaceutical sales reps in the field this year than there have been in the past, it's because there are.

Contrary to popular opinion, possession of knowledge is not power. Utilization of knowledge is power.

Wholesaler preferred generics programs encourage price competition that benefits Medicare and Medicaid programs and, therefore, do not violate anti-kickback statutes, according to an advisory opinion released by the Health and Human Services Office of the Inspector General in April.

Elan Corp., Dublin, Ireland, will acquire Carnrick Laboratories from GWC Health Inc. for $150 million, élan announced in late April.

Sales reps prove that devoting a little time and effort make a big difference.

Pharmaceutical companies were portrayed as aggressive, money-hungry and even nosy in articles on patient privacy issues in the Wall Street Journal on April 17.

Rep must not forget what they should NOT do on a sales call, so they don't shoot ourselves in the foot on the way in or out of a doctor's office.

The number of commercially insured patients who used indemnity plans in 1997 was drastically lower than it was in 1993, according to a new report from Mountain View, CA-based strategic research firm Frost & Sullivan.

A prescription drug that has been on the market for the past 20 years may actually prevent breast cancer, according to new research.

Paul Pinsonault, president of Pinsonault Associates, a managed care educational organization, spoke briefly with Pharmaceutical Representative on recent trends in managed care.

Greater devotion to the research and development of novel biotechnology medicines is gaining momentum with pharmaceutical and biotechnology companies, according to a recent report from the Pharmaceutical Research and Manufacturers of America.

Adverse drug reactions in hospitals could be a leading cause of death in the United States, according to a controversial study published in the April 14 issue of The Journal of American Medical Association.

The rate of sales growth in North America and selected international markets grew by 6% from February 1997 to January 1998, according to a recent "Drug Monitor" report from IMS Global Services. Final sales closed at $181 billion.

Sort your sales strategy according to your customers.

Last November, President Clinton formally signed into law the Food and Drug Administration Modernization Act, sweeping bipartisan congressional legislation focused on reforming the agency's regulation of food, drugs, medical devices and cosmetics. Overall, the new law is considered a triumph by both the Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization because it embraces many of the FDA legislative reform recommendations the industries had proposed to streamline the drug regulatory process.

Pam Bailey, Jim LaMartina and Andy Hartnett have joined Pharmaceutical Representative's editorial advisory board, boosting the number of members to 13.

REP PROFILE

Overcoming those bad days.